Malawi rolls out injectable HIV prevention drug amid hope and caution
Malawi is introducing a new injectable HIV prevention drug, Lenacapavir, which has shown high efficacy in clinical trials. The rollout comes as local health advocates continue to fight stigma and improve access to care for those living with the virus.
Why it matters
New long-acting injectable treatments represent a major breakthrough in global public health, potentially increasing adherence and reducing HIV transmission rates.
"I've faced stigma from the community and workplaces," the soft-spoken man, who sat at a desk in a small office off the road connecting the tea-growing district of Thyolo with the commercial city of Blantyre, told RFI in an interview.
Chakwana came out publicly with his status immediately after diagnosis, informing his workmates and community. The backlash from his employer was swift.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in